Prevalence of Adverse Event Reporting in Adolescents and Young Adults Enrolled in Cancer Clinical Trials

Keyphrases

• Older Adults 100%
• In Cancer 100%
• Cancer Clinical Trials 100%
• Adverse Event Reporting 100%
• Adult Cancer 30%
• Improved Outcomes 20%
• Breast Cancer 20%
• Colorectal Cancer 20%
• Adverse Event Data 20%
• Treatment Delay 10%
• Clinical Trials 10%
• Adverse Events 10%
• Undertreatment 10%
• Treatment Regimen 10%
• Non-Hodgkin Lymphoma 10%
• Melanoma 10%
• Young Population 10%
• Older Patients 10%
• Young Patients 10%
• Event Frequency 10%
• Cancer Treatment 10%
• Reduction Method 10%
• All-phase 10%
• Treatment Discontinuation 10%
• Hodgkin Lymphoma 10%
• Lymphoma non-Hodgkin 10%
• Young-old 10%
• Treatment Tolerance 10%
• Public Domain 10%
• Drug Delivery 10%
• Treatment Toxicity 10%
• Observational Design 10%
• Treatment Optimization 10%
• Event Severity 10%
• Cancer-directed Therapy 10%
• Dose Reduction 10%
• Overtreatment 10%

Medicine and Dentistry

• Prevalence 100%
• Adverse Event 100%
• Clinical Trial 100%
• Malignant Neoplasm 100%
• Adolescence 100%
• Cancer in Young Adults 16%
• Non-Hodgkin Lymphoma 8%
• Breast Cancer 8%
• Colorectal Carcinoma 8%
• Cancer Therapy 8%
• Hodgkin's Lymphoma 8%
• Drug Dose Reduction 8%
• Therapy Delay 8%
• Melanoma 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Prevalence 100%
• Adverse Event 100%
• Clinical Trial 100%
• Malignant Neoplasm 100%
• Nonhodgkin Lymphoma 14%
• Breast Cancer 14%
• Melanoma 14%
• Colorectal Carcinoma 14%
• Hodgkin Disease 14%